Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Hepatitis: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Hepatitis is a disease characterized by neurodegeneration research. Key relationships include: therapeutic target, activates, associated with. Associated with Aging, Als, Alzheimer. Connected to 690 entities in the SciDEX knowledge graph.
No AI portrait yet
| Associated Genes | AHR, AKT, AKT1, AND, APOPTOSIS, ASC, ATF6, ATG |
| KG Connections | 792 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
graph TD
Hepatitis["Hepatitis"] -->|"therapeutic target"| Apoptosis["Apoptosis"]
Hepatitis["Hepatitis"] -->|"contributes to"| Pyroptosis["Pyroptosis"]
Hepatitis["Hepatitis"] -->|"contributes to"| Necroptosis["Necroptosis"]
Hepatitis["Hepatitis"] -->|"contributes to"| Apoptosis_1["Apoptosis"]
Hepatitis["Hepatitis"] -.->|"inhibits"| Cholesterol["Cholesterol"]
Hepatitis["Hepatitis"] -->|"contributes to"| Ferroptosis["Ferroptosis"]
SRPK1["SRPK1"] -->|"therapeutic target"| Hepatitis["Hepatitis"]
FASN["FASN"] -.->|"inhibits"| Hepatitis["Hepatitis"]
BAX["BAX"] -.->|"inhibits"| Hepatitis["Hepatitis"]
ALOX15["ALOX15"] -.->|"inhibits"| Hepatitis["Hepatitis"]
style Hepatitis fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | activates | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Als | associated_with | disease | 0.95 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Inflammation | inhibits | disease | 0.85 |
| Cholesterol | therapeutic_target | pathway | 0.80 |
| Autophagy | therapeutic_target | pathway | 0.80 |
| Cholesterol | activates | pathway | 0.80 |
| Unfolded Protein Response | therapeutic_target | pathway | 0.80 |
| Mtor | therapeutic_target | pathway | 0.80 |
| Fatty Liver | associated_with | disease | 0.75 |
| Fatty Liver | activates | disease | 0.75 |
| Apoptosis | inhibits | pathway | 0.70 |
| Oxidative Stress | inhibits | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Lipid Metabolism | activates | pathway | 0.70 |
| Lipid Metabolism | therapeutic_target | pathway | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| Lipid Metabolism | regulates | pathway | 0.70 |
| Autophagy | associated_with | pathway | 0.70 |
| Lipid Metabolism | associated_with | pathway | 0.70 |
| Apoptosis | associated_with | pathway | 0.70 |
| Ferroptosis | therapeutic_target | pathway | 0.70 |
| Epigenetic | therapeutic_target | pathway | 0.70 |
| Oxidative Stress | associated_with | pathway | 0.70 |
| Complement | therapeutic_target | pathway | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| Immune Response | regulates | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| Obesity | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| FIBROSIS | interacts_with | disease | 0.65 |
| MACROPHAGE | regulates | cell_type | 0.65 |
| Als | activates | disease | 0.65 |
| Autoimmune | associated_with | disease | 0.65 |
| Fatty Liver | therapeutic_target | disease | 0.65 |
| Wnt | therapeutic_target | pathway | 0.60 |
| Notch | therapeutic_target | pathway | 0.60 |
| Inflammasome | therapeutic_target | pathway | 0.60 |
| Er Stress | therapeutic_target | pathway | 0.60 |
| Microrna | associated_with | pathway | 0.60 |
| Akt | activates | pathway | 0.60 |
| Epigenetic | activates | pathway | 0.60 |
| Autophagy | inhibits | pathway | 0.60 |
| Mtor | inhibits | pathway | 0.60 |
| Er Stress | activates | pathway | 0.60 |
| Unfolded Protein Response | activates | pathway | 0.60 |
| Histone Modification | associated_with | pathway | 0.60 |
| Oxidative Stress | regulates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | associated_with | gene | 1.00 |
| INFLAMMATION | associated_with | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| Fibrosis | associated_with | disease | 1.00 |
| Carcinoma | associated_with | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| Infection | associated_with | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| GENES | activates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Cirrhosis | associated_with | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | activates | gene | 0.95 |
| CANCER | activates | gene | 0.95 |
| Fibrosis | biomarker_for | disease | 0.95 |
| Fibrosis | therapeutic_target | disease | 0.95 |
| GENES | therapeutic_target | gene | 0.95 |
| Als | associated_with | disease | 0.95 |
| Hepatocellular Carcinoma | associated_with | disease | 0.95 |
| lipophagy | prevents | process | 0.88 |
| OXIDATIVE STRESS | associated_with | gene | 0.85 |
| BAX | inhibits | gene | 0.85 |
| Liver Cancer | associated_with | disease | 0.85 |
| MTOR | therapeutic_target | gene | 0.85 |
| CYTOKINES | associated_with | gene | 0.85 |
| MTORC1 | therapeutic_target | gene | 0.85 |
| TNF | inhibits | gene | 0.85 |
| AUTOPHAGY | therapeutic_target | gene | 0.85 |
| CANCER | therapeutic_target | gene | 0.85 |
| MITOCHONDRIA | therapeutic_target | gene | 0.85 |
| FERROPTOSIS | therapeutic_target | gene | 0.85 |
| GENES | associated_with | gene | 0.85 |
| OXIDATIVE STRESS | activates | gene | 0.85 |
| GENES | inhibits | gene | 0.85 |
| FERROPTOSIS | activates | gene | 0.75 |
| INSULIN RESISTANCE | activates | gene | 0.75 |
| CYTOKINES | activates | gene | 0.75 |
| Cirrhosis | biomarker_for | disease | 0.75 |
| CLDN1 | therapeutic_target | gene | 0.75 |
| Metabolic Syndrome | associated_with | disease | 0.75 |
| Diabetes | associated_with | disease | 0.75 |
| PTGS2 | therapeutic_target | gene | 0.75 |
| CANCER | regulates | gene | 0.75 |
| MICRORNAS | therapeutic_target | gene | 0.75 |
| GENES | treats | gene | 0.75 |
| OVERVIEW | associated_with | gene | 0.75 |
| OXIDATIVE STRESS | inhibits | gene | 0.75 |
| NRF2 | inhibits | gene | 0.75 |
| RAS | inhibits | gene | 0.75 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Hepatitis in their description or question text
No additional research found